Clinical-stage healthcare innovation · Helix, New Jersey

Shortening the distance between discovery and the patient.

FamaMedic Inc develops AI-optimized repurposed molecules, wearable health technology, and AR-enabled care tools for chronic conditions of unmet clinical need — built to reach people across North America, Europe, the Middle East, and Africa.

Partner with us See the roadmap

Five objectives, plotted against real dates.

Corporate roadmap · 2026 →

Repurposed synthetic molecules to Phase 2A Target · 18 months

Scale AI-optimized repurposed molecules into Phase 2A trials for chronic conditions of unmet clinical need.

Global OTC retail and e-commerce presence Target · 2027

Distribution across North America, Europe, the Middle East, and Africa.

Wearable health-tech division In progress

Monitoring integrated with therapeutic response for chronic non-healing wounds, endometriosis, pregnancy-related complications, and chronic disease care.

FamaMedic Inc Labs In progress

A multidisciplinary innovation hub to accelerate R&D, host medical fellowships, and incubate next-generation therapeutic technologies.

Global health agency partnerships Continuing

Working toward affordable and equitable access to FamaMedic's most impactful innovations.

◆ Green node marks the stated completion milestone. Open bars indicate ongoing programs without a fixed end date.

5OTC products
invented

4Medical devices
developed

4Repurposed medicines
in the pipeline

15Peer-reviewed
publications

What we build

Three lines of work, one connective layer.

AI and augmented reality run through everything we develop — shaping which molecules we pursue, how devices interpret what they measure, and how clinicians and patients act on the result.

Repurposed synthetic molecules

AI-optimized candidates selected for chronic conditions where existing treatment falls short, advancing toward Phase 2A trials.

Preclinical → Phase 2AUnmet need

Wearable health technology

Devices that pair continuous monitoring with therapeutic response, so a change in the data can trigger a change in care.

4 devicesMonitor + treat

Consumer therapeutics

Five over-the-counter products already invented across chronic fatigue, flu, menopause, and anti-aging, heading to retail and e-commerce worldwide.

5 OTC products4 regions by 2027

Therapeutic focus

Conditions people live with for years.

Our programs concentrate on long-running conditions where daily burden is high, treatment options are limited, and monitoring changes what care can do.

Wound careChronic non-healing wounds

Women's healthEndometriosis

Maternal healthPregnancy-related complications

Long-term careChronic disease management

OTCChronic fatigue

OTCInfluenza

OTCMenopause

OTCAnti-aging

Leadership

Founded by a physician who builds what the clinic is missing.

Dr. Adedapo, CEO and President of FamaMedic Inc — Dr. Adedapo Adesokan

CEO & President, FamaMedic Inc

Physician · Clinical pharmacologist · Inventor

Dr. Adedapo's work runs from preclinical development through human trials to licensing, with a particular interest in conceptualizing novel therapies for unmet clinical needs. He led Precismed Limited as CEO for nine years before taking on the role of CEO and President of FamaMedic Inc.

Medicine: MBBS — University of Ilorin, Nigeria
Postgraduate: MSc Clinical Pharmacology & PhD Therapeutics — University of Glasgow
Residency: Emergency Medicine — NHS Sherwood Forest, England
Invented: 5 OTC products · 4 medical devices · 4 repurposed medicines in pipeline
Published: 15 peer-reviewed articles across emergency medicine, clinical pharmacology, and drug and device discovery

Leadership principle

TPPE — VPAH — ADAPT

The framework Dr. Adedapo developed for building a research-led company, and the spine of his forthcoming book.

The Making of the Physician-Entrepreneur Serial Biotech Inventor: The TPPE-VPAH-ADAPT Principle

Partnerships

Bring us a problem worth solving properly.

We work with researchers, healthcare professionals, manufacturers, clinical research organizations, technology developers, distributors, and investors who share our commitment to responsible healthcare innovation.

01Research and academic collaboration

02Clinical evaluation

03Product manufacturing

04Technology development

05Distribution and licensing

06Investment and funding

07Regulatory and commercial development

08Something we haven't listed — tell us

Tell us where you fit, and we'll come back with the right person on our side.

Partner with us Ask a question